Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone

BACKGROUND: Inhaled corticosteroids (ICS) afford therapeutic benefits in some COPD patients, but their widespread use is cautioned due to an increased risk of developing pneumonia. Subclass variations exist, and the risk profile differs for individual ICS. Formulation particle size has been identifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Price, David B, Henley, William, Cançado, José Eduardo Delfini, Fabbri, Leonardo M, Kerstjens, Huib A M, Papi, Alberto, Roche, Nicolas, Şen, Elif, Singh, Dave, Vogelmeier, Claus F, Barille, Sara, Nudo, Elena, Carter, Victoria, Skinner, Derek, Vella, Rebecca, Georges, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858000/
https://www.ncbi.nlm.nih.gov/pubmed/35210765
http://dx.doi.org/10.2147/COPD.S342357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858000/
https://www.ncbi.nlm.nih.gov/pubmed/35210765
http://dx.doi.org/10.2147/COPD.S342357

Ejemplares similares